Total Payments
$73,896
2024 Payments
$4,140
Companies
8
Transactions
78
Medicare Patients
1,055
Medicare Billing
$82,821
Payment Breakdown by Category
Other$40,900 (55.3%)
Consulting$22,627 (30.6%)
Travel$9,382 (12.7%)
Food & Beverage$722.15 (1.0%)
Education$264.93 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,900 | 21 | 55.3% |
| Consulting Fee | $22,627 | 8 | 30.6% |
| Travel and Lodging | $9,382 | 23 | 12.7% |
| Food and Beverage | $722.15 | 23 | 1.0% |
| Education | $264.93 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $48,237 | 50 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13,739 | 5 | $0 (2024) |
| ARGENX US, INC. | $7,560 | 5 | $0 (2024) |
| Eli Lilly and Company | $2,500 | 1 | $0 (2022) |
| Regeneron Pharmaceuticals, Inc. | $1,416 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $264.93 | 3 | $0 (2024) |
| ABBVIE INC. | $165.20 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $13.55 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,140 | 13 | ARGENX US, INC. ($1,500) |
| 2023 | $28,075 | 23 | Lilly USA, LLC ($18,532) |
| 2022 | $41,012 | 39 | Lilly USA, LLC ($29,206) |
| 2021 | $578.99 | 2 | Lilly USA, LLC ($499.00) |
| 2020 | $89.95 | 1 | Janssen Biotech, Inc. ($89.95) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $67.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $47.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $731.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $35.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $94.99 | General |
| Category: Immunology | ||||||
| 08/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,112.20 | General |
| 06/13/2024 | ARGENX US, INC. | VYVGART (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Immunology | ||||||
| 12/15/2023 | ARGENX US, INC. | VYVGART (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunology | ||||||
| 10/31/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,350.00 | General |
| 07/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Consulting Fee | Cash or cash equivalent | $4,068.75 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: IMMUNOLOGY | ||||||
| 05/12/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $12.38 | General |
| Category: Immunology | ||||||
| 05/12/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | Cash or cash equivalent | $7.80 | General |
| Category: Immunology | ||||||
| 05/01/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 05/01/2023 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: Immunology | ||||||
| 04/25/2023 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $2,871.88 | General |
| 04/25/2023 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $296.20 | General |
| 04/25/2023 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $180.94 | General |
| 04/25/2023 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $176.89 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 297 | 557 | $72,275 | $23,871 |
| 2022 | 11 | 289 | 540 | $70,772 | $23,304 |
| 2021 | 9 | 250 | 504 | $56,798 | $19,377 |
| 2020 | 7 | 219 | 387 | $56,928 | $16,269 |
Total Patients
1,055
Total Services
1,988
Medicare Billing
$82,821
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 119 | $27,682 | $9,775 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 84 | $13,254 | $5,018 | 37.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 26 | $4,123 | $1,610 | 39.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $4,242 | $1,425 | 33.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 16 | 22 | $6,694 | $1,402 | 20.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 12 | 15 | $3,624 | $1,274 | 35.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 31 | 37 | $6,433 | $1,104 | 17.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $2,483 | $714.12 | 28.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 29 | 61 | $522.55 | $482.04 | 92.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 16 | 39 | $964.86 | $403.65 | 41.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 21 | 89 | $1,511 | $358.49 | 23.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 18 | 40 | $741.20 | $304.40 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 117 | $25,906 | $10,361 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 83 | $12,749 | $4,863 | 38.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 18 | 23 | $5,540 | $1,705 | 30.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 24 | 31 | $9,548 | $1,624 | 17.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,095 | $1,559 | 38.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 30 | 40 | $7,095 | $1,176 | 16.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 14 | $2,086 | $779.38 | 37.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 24 | 98 | $1,759 | $412.78 | 23.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 15 | 38 | $940.12 | $396.29 | 42.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 15 | 38 | $704.14 | $291.50 | 41.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 46 | $350.98 | $136.17 | 38.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 85 | $18,414 | $7,466 | 40.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 88 | $13,233 | $5,483 | 41.4% |
About Dr. Jamie Rhoads, M.D
Dr. Jamie Rhoads, M.D is a Dermatology healthcare provider based in Murray, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1104093392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamie Rhoads, M.D has received a total of $73,896 in payments from pharmaceutical and medical device companies, with $4,140 received in 2024. These payments were reported across 78 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($40,900).
As a Medicare-enrolled provider, Rhoads has provided services to 1,055 Medicare beneficiaries, totaling 1,988 services with total Medicare billing of $82,821. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Murray, UT
- Active Since 05/15/2008
- Last Updated 11/15/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1104093392
Products in Payments
- Olumiant (Drug) $26,873
- OLUMIANT (Drug) $13,826
- VYVGART (Drug) $7,560
- SPEVIGO (Drug) $4,069
- DUPIXENT (Biological) $1,416
- TALTZ (Drug) $638.31
- TREMFYA (Drug) $264.93
- RINVOQ (Biological) $165.20
- SAPHNELO (Biological) $13.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Murray
Dr. Sancy Leachman, M.d, M.D
Dermatology — Payments: $39,464
Dermatology $39,464
Dr. James Outland
Dermatology — Payments: $7,810
Dermatology $7,810
Dr. Rebekah Clifford, Md, MD
Dermatology — Payments: $1,124
Dermatology $1,124
Luke Johnson, Md, MD
Dermatology — Payments: $893.79
Dermatology $893.79
Dr. John Bright, D.o, D.O
Dermatology — Payments: $120.00
Dermatology $120.00
Jeanna Ryan, Rd, RD
Dermatology — Payments: $89.99
Dermatology $89.99